Merus N.V.
MRUSNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for MRUS. That does not mean none is planned.
Get an email about MRUS's next catalysts
Track Merus (MRUS) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
Petosemtamab
Head and Neck Squamous Cell Carcinoma
MCLA-158
Advanced/Metastatic Solid Tumors
Zenocutuzumab
Breast Cancer Metastatic
MCLA-129
Non-Small Cell Lung Cancer Metastatic
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Petosemtamab | Phase 3 | Head and Neck Squamous Cell Carcinoma | - | - |
MCLA-158 | Phase 2 | Advanced/Metastatic Solid Tumors | - | - |
Zenocutuzumab | Phase 2 | Breast Cancer Metastatic | - | - |
MCLA-129 | Phase 2 | Non-Small Cell Lung Cancer Metastatic | - | - |
Head and Neck Squamous Cell Carcinoma
2 drugs in this indication
Breast Cancer Metastatic
1 drug in this indication
Advanced/Metastatic Solid Tumors
1 drug in this indication
Non-Small Cell Lung Cancer Metastatic
1 drug in this indication
First-line recurrent or metastatic PD-L1-positive head and neck squamous cell carcinoma (HNSCC)
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Merus N.V.'s drug pipeline?β
CatalystAlert tracks 4 drug candidates in Merus N.V.'s (MRUS) pipeline across Phase 3, Phase 2. Its lead program is Petosemtamab (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Merus N.V.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Merus N.V. (MRUS) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track MRUS biotech catalysts?β
Add MRUS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Merus N.V.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
